Aspirin exacerbated respiratory disease: Current topics and trends
- 1 February 2018
- journal article
- review article
- Published by Elsevier in Respiratory Medicine
- Vol. 135, 62-75
Abstract
No abstract availableKeywords
This publication has 156 references indexed in Scilit:
- Rhinosinusitis and Nasal Polyps in Aspirin-Exacerbated Respiratory DiseaseImmunology and Allergy Clinics of North America, 2013
- Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytesBlood, 2012
- Niacin and biosynthesis of PGD2 by platelet COX-1 in mice and humansJournal of Clinical Investigation, 2012
- Evidence for distinct histologic profile of nasal polyps with and without eosinophiliaThe Laryngoscope, 2011
- Targeted eicosanoid lipidomics of exhaled breath condensate provide a distinct pattern in the aspirin-intolerant asthma phenotypeJournal of Allergy and Clinical Immunology, 2011
- Update on Recent Advances in the Management of Aspirin Exacerbated Respiratory DiseaseYonsei Medical Journal, 2009
- Control of salicylate intolerance with fish oilsBritish Journal of Dermatology, 2008
- A systematic review of the use of intranasal steroids in the treatment of chronic rhinosinusitisOtolaryngology–Head and Neck Surgery, 2008
- Concordant Modulation of Cysteinyl Leukotriene Receptor Expression by IL-4 and IFN-γ on Peripheral Immune CellsAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- The broken balance in aspirin hypersensitivityEuropean Journal of Pharmacology, 2006